Cargando…

Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models

Mathematical models have been applied in prediction of growth hormone treatment effectiveness in children since the end of 1990s. Usually they were multiple linear regression models; however, there are also examples derived by empirical non-linear methods. Proposed solution consists in application o...

Descripción completa

Detalles Bibliográficos
Autores principales: Smyczyńska, Urszula, Smyczyńska, Joanna, Hilczer, Maciej, Stawerska, Renata, Tadeusiewicz, Ryszard, Lewiński, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793807/
https://www.ncbi.nlm.nih.gov/pubmed/29242356
http://dx.doi.org/10.1530/EC-17-0277
_version_ 1783297025099431936
author Smyczyńska, Urszula
Smyczyńska, Joanna
Hilczer, Maciej
Stawerska, Renata
Tadeusiewicz, Ryszard
Lewiński, Andrzej
author_facet Smyczyńska, Urszula
Smyczyńska, Joanna
Hilczer, Maciej
Stawerska, Renata
Tadeusiewicz, Ryszard
Lewiński, Andrzej
author_sort Smyczyńska, Urszula
collection PubMed
description Mathematical models have been applied in prediction of growth hormone treatment effectiveness in children since the end of 1990s. Usually they were multiple linear regression models; however, there are also examples derived by empirical non-linear methods. Proposed solution consists in application of machine learning technique – artificial neural networks – to analyse this problem. This new methodology, contrary to previous ones, allows detection of both linear and non-linear dependencies without assuming their character a priori. The aims of this work included: development of models predicting separately growth during 1st year of treatment and final height as well as identification of important predictors and in-depth analysis of their influence on treatment’s effectiveness. The models were derived on the basis of clinical data of 272 patients treated for at least 1 year, 133 of whom have already attained final height. Starting from models containing 17 and 20 potential predictors, respectively for 1st year and final height model, we were able to reduce their number to 9 and 10. Basing on the final models, IGF-I concentration and earlier growth were indicated as belonging to most important predictors of response to GH therapy, while results of GH secretion tests were automatically excluded as insignificant. Moreover, majority of the dependencies were observed to be non-linear, thus using neural networks seems to be reasonable approach despite it being more complex than previously applied methods.
format Online
Article
Text
id pubmed-5793807
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-57938072018-02-06 Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models Smyczyńska, Urszula Smyczyńska, Joanna Hilczer, Maciej Stawerska, Renata Tadeusiewicz, Ryszard Lewiński, Andrzej Endocr Connect Research Mathematical models have been applied in prediction of growth hormone treatment effectiveness in children since the end of 1990s. Usually they were multiple linear regression models; however, there are also examples derived by empirical non-linear methods. Proposed solution consists in application of machine learning technique – artificial neural networks – to analyse this problem. This new methodology, contrary to previous ones, allows detection of both linear and non-linear dependencies without assuming their character a priori. The aims of this work included: development of models predicting separately growth during 1st year of treatment and final height as well as identification of important predictors and in-depth analysis of their influence on treatment’s effectiveness. The models were derived on the basis of clinical data of 272 patients treated for at least 1 year, 133 of whom have already attained final height. Starting from models containing 17 and 20 potential predictors, respectively for 1st year and final height model, we were able to reduce their number to 9 and 10. Basing on the final models, IGF-I concentration and earlier growth were indicated as belonging to most important predictors of response to GH therapy, while results of GH secretion tests were automatically excluded as insignificant. Moreover, majority of the dependencies were observed to be non-linear, thus using neural networks seems to be reasonable approach despite it being more complex than previously applied methods. Bioscientifica Ltd 2017-12-14 /pmc/articles/PMC5793807/ /pubmed/29242356 http://dx.doi.org/10.1530/EC-17-0277 Text en © 2018 The authors http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research
Smyczyńska, Urszula
Smyczyńska, Joanna
Hilczer, Maciej
Stawerska, Renata
Tadeusiewicz, Ryszard
Lewiński, Andrzej
Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
title Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
title_full Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
title_fullStr Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
title_full_unstemmed Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
title_short Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
title_sort pre-treatment growth and igf-i deficiency as main predictors of response to growth hormone therapy in neural models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793807/
https://www.ncbi.nlm.nih.gov/pubmed/29242356
http://dx.doi.org/10.1530/EC-17-0277
work_keys_str_mv AT smyczynskaurszula pretreatmentgrowthandigfideficiencyasmainpredictorsofresponsetogrowthhormonetherapyinneuralmodels
AT smyczynskajoanna pretreatmentgrowthandigfideficiencyasmainpredictorsofresponsetogrowthhormonetherapyinneuralmodels
AT hilczermaciej pretreatmentgrowthandigfideficiencyasmainpredictorsofresponsetogrowthhormonetherapyinneuralmodels
AT stawerskarenata pretreatmentgrowthandigfideficiencyasmainpredictorsofresponsetogrowthhormonetherapyinneuralmodels
AT tadeusiewiczryszard pretreatmentgrowthandigfideficiencyasmainpredictorsofresponsetogrowthhormonetherapyinneuralmodels
AT lewinskiandrzej pretreatmentgrowthandigfideficiencyasmainpredictorsofresponsetogrowthhormonetherapyinneuralmodels